Literature DB >> 24891775

Role of Subfascial Endoscopic Perforator Surgery (SEPS) in Management of Perforator Incompetence in Varicose Veins : A Prospective Randomised Study.

M G Vashist1, Vijay Malik1, Nitin Singhal1.   

Abstract

The study was carried out to compare the efficacy of subfascial endoscopic perforator surgery (SEPS) and open subfascial ligation of perforators in varicose veins. This study was conducted on 100 patients of varicose veins from January 2006 to December 2010. Clinical scoring and color Doppler were performed in all the patients before surgery. Patients were divided into two groups: Group A and Group B alternately. Management of the perforators was done by subfascial endoscopic perforator surgery (SEPS) in Group A and by open subfascial ligation of perforators in Group B. Fifty patients were treated in each group. All the patients underwent ligation of incompetent saphenofemoral junction with stripping of long saphenous veins wherever the junction was incompetent with multiple ligation of superficial prominent veins. SEPS was done by two-port method without any tourniquet or balloon dissector. Total numbers of perforators ligated were 178 in Group A and 136 in Group B. Patients in both the groups got symptomatic relief of symptoms, but ulcer healing in 33 % patients in Group A was faster as compared to Group B. However, at 3 months of follow-up the ulcers healed in all the patients in both groups. Incidence of wound infection was higher in group B (16 %) as compared to group A (0 %). There were residual perforators in 8 % of patients on color Doppler at 3 months of follow-up in Group B while there was no residual incompetent perforator in Group A. Subfascial endoscopic perforator vein surgery is a safe and effective method for treating incompetent perforating veins. The number of perforators ligated in SEPS was more as compared to the open subfascial ligation group. Possibly some perforators may be missed on Doppler localization and missed ligation, which may be a cause of future recurrence in varicose veins. Early relief of symptoms in terms of ulcer healing was better in the SEPS group with less wound complication rate; however, all the ulcers healed in both the groups at 3 months of follow-up. Cosmetic results were equal in both the groups. Major advantage of SEPS was less incidence of wound complications and less incidence of residual incompetent perforators. Hence, SEPS should be added for the management of perforators along with conventional surgery in varicose veins.

Entities:  

Keywords:  Perforator incompetence; Subfascial endoscopic perforator surgery; Varicose veins

Year:  2012        PMID: 24891775      PMCID: PMC4039691          DOI: 10.1007/s12262-012-0675-5

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  20 in total

1.  Efficacy of subfascial endoscopy in eradicating perforating veins of the lower leg and its relation with venous ulcer healing.

Authors:  E G Pierik; H van Urk; C H Wittens
Journal:  J Vasc Surg       Date:  1997-08       Impact factor: 4.268

2.  Primary deep venous incompetence in limbs with varicose veins.

Authors:  B Almgren; I Eriksson
Journal:  Acta Chir Scand       Date:  1989-09

3.  Safety, feasibility, and early efficacy of subfascial endoscopic perforator surgery: a preliminary report from the North American registry.

Authors:  P Gloviczki; J J Bergan; S S Menawat; R W Hobson; R L Kistner; P F Lawrence; A Lumsden; T F O'Donnell; R G DePalma; J Murray; J P Pigott; H Schanzer; E Ascer; P Kalman; K D Calligaro; J L Ballard; R A Cambria; R Y Rhee; B G Rubin; D M Ilstrup; W S Harmsen; L G Canton
Journal:  J Vasc Surg       Date:  1997-01       Impact factor: 4.268

4.  Mid-term recurrence rate of incompetent perforating veins after combined superficial vein surgery and subfascial endoscopic perforating vein surgery.

Authors:  Florian Roka; Michael Binder; Kornelia Bohler-Sommeregger
Journal:  J Vasc Surg       Date:  2006-08       Impact factor: 4.268

5.  Subfascial endoscopic perforator surgery ameliorates the symptoms of chronic venous ulcer (C6) patients.

Authors:  A T Kurdal; M Cerrahoglu; I Iskesen; M Eserdag; H Sirin
Journal:  Int Angiol       Date:  2010-02       Impact factor: 2.789

6.  Endoscopic subfascial perforator vein surgery for patients with severe, chronic venous insufficiency.

Authors:  Howard C Baron; Michael G Wayne; Cesar A Santiago; Robert Grossi
Journal:  Vasc Endovascular Surg       Date:  2004 Sep-Oct       Impact factor: 1.089

7.  The role of primary varicose veins in venous ulceration.

Authors:  M C Hoare; A N Nicolaides; C R Miles; K Shull; R P Jury; T Needham; H A Dudley
Journal:  Surgery       Date:  1982-09       Impact factor: 3.982

Review 8.  Surgical treatment of venous ulcers: role of subfascial endoscopic perforator vein ligation.

Authors:  Manju Kalra; Peter Gloviczki
Journal:  Surg Clin North Am       Date:  2003-06       Impact factor: 2.741

Review 9.  Meta-analysis of subfascial endoscopic perforator vein surgery (SEPS) for chronic venous insufficiency.

Authors:  T Luebke; J Brunkwall
Journal:  Phlebology       Date:  2009-02       Impact factor: 1.740

10.  Subfascial endoscopic perforator vein surgery using balloon dissector and saphenous vein surgery in chronic venous insufficiency.

Authors:  H Uncu
Journal:  Phlebology       Date:  2007       Impact factor: 1.740

View more
  2 in total

Review 1.  S2k guidelines: diagnosis and treatment of varicose veins.

Authors:  F Pannier; T Noppeney; J Alm; F X Breu; G Bruning; I Flessenkämper; H Gerlach; K Hartmann; B Kahle; H Kluess; E Mendoza; D Mühlberger; A Mumme; H Nüllen; K Rass; S Reich-Schupke; D Stenger; M Stücker; C G Schmedt; T Schwarz; J Tesmann; J Teßarek; S Werth; E Valesky
Journal:  Hautarzt       Date:  2022-04-19       Impact factor: 1.198

2.  Subfascial Endoscopic Perforator Surgery: A safe and novel minimal invasive procedure in treating varicose veins in 2nd trimester of pregnancy for below knee perforator incompetence.

Authors:  Manash Ranjan Sahoo; Leesa Misra; Sumeet Deshpande; Sambit Kumar Mohanty; Santosh Kumar Mohanty
Journal:  J Minim Access Surg       Date:  2018 Jul-Sep       Impact factor: 1.407

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.